Intermittent Cushing's syndrome with anomalous response to dexamethasone.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000311:Adrenal Glands / Q000187:drug effects*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D003480:Cushing Syndrome / Q000378:metabolism*; D003907:Dexamethasone / Q000494:pharmacology*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000378:metabolism / Q000652:urine; D008297:Male; D008797:Metyrapone / Q000494:pharmacology; D008875:Middle Aged; D009318:Natriuresis; D011188:Potassium / Q000652:urine; D011749:Pyrogens / Q000494:pharmacology; D012636:Secretory Rate
D015065:17-Hydroxycorticosteroids; D011749:Pyrogens; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D011188:Potassium; D006854:Hydrocortisone; D008797:Metyrapone